Healthcare Stock Comparisons
Small-Cap Healthcare Stocks Compared While TransMedics Shares Fall Sharply
Anonymous
Several reports compared small-cap health care stocks, with Sunshine Biopharma rated more favorably than Aditxt, Apyx Medical beating Biomerica, Profound Medical outperforming Tenon Medical, and Eloxx Pharmaceuticals prevailing over Addex Therapeutics on most of the factors assessed. Analyst ratings and price targets favored Sunshine, Profound and Eloxx, while Apyx’s comparison highlighted its greater institutional ownership and lower price-to-earnings ratio. Separately, TransMedics shares fell 3.6% and were down sharply over the past year; GuruFocus estimated the stock traded 47.2% below its GF Value, but cautioned that the valuation could signal a value trap. TransMedics received a GF Score of 74 out of 100, and reported insider net selling over the past year.
Key Points
1
Sunshine Biopharma’s consensus price target was $70, which the report calculated as a potential 8,207.62% upside; institutional investors held 42.0% of its shares, compared with 15.5% of Aditxt’s.
2
Apyx Medical’s beta was 1.31, versus 0.37 for Biomerica, meaning Apyx shares were characterized as more volatile relative to the S&P 500 despite its stronger overall comparison.
3
Profound Medical had a beta of 0.72, compared with 1.36 for Tenon Medical; institutional investors owned 47.9% of Profound shares and 22.7% of Tenon shares.
4
The Eloxx–Addex comparison reported an unusually extreme beta of -1,862.26 for Eloxx, versus 1.47 for Addex; insiders owned 25.9% of Eloxx shares, compared with 15.0% of Addex shares.
5
TransMedics’ price-to-earnings ratio was 21.8, below its five-year median of 59.2; its GuruFocus score was strongest for growth (9/10) and weakest for profitability (3/10).
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
13
Articles
15
Reach
28
A
AnonymousAuthor
